Dutasterid-Tamsulosin Xiromed 0,5 mg/0,4 mg, Hartkapseln

7680682120024 CH-68212 Kapseln
Dutasterid-Tamsulosin Xiromed 0,5 mg/0,4 mg, Hartkapseln
Dutasterid-Tamsulosin Xiromed 0,5 mg/0,4 mg, Hartkapseln
Dutasterid-Tamsulosin Xiromed 0,5 mg/0,4 mg, Hartkapseln
1 / 3
google

Article details

Package size
30
Selling units
30
Measure
Kapsel(n)
Galenic form
Kapseln
Galenic group
Tabletten

Official Swissmedic V2 data

Additional information from the official database

Official medical documents

Patient information leaflet
Allemand
19/02/2026
Patient information leaflet
Français
19/02/2026
Patient information leaflet
Italien
19/02/2026
Summary of Product Characteristics
Allemand
19/02/2026
Summary of Product Characteristics
Français
19/02/2026
Summary of Product Characteristics
Italien
19/02/2026

Detailed composition

Substance Quantity Type Category
dutasteridum
0.5 MG Substance Wirkstoff (Principe actif)
tamsulosini hydrochloridum
0.4 MG Substance Wirkstoff (Principe actif)
tamsulosinum
0.367 MG Substance WIZUS
propylenglycoli monocaprylas
- Substance HNIDK
propylenglycolum
112.65 MG Substance HBESI
E 321
- Substance ANTOX
gelatina
- Substance HNIDK
E 171
- Substance FNIDK
glycerolum
- Substance HNIDK
triglycerida media
- Substance HNIDK
lecithinum ex soja
- Substance HNIDK
acidi methacrylici et ethylis acrylatis polymerisatum 1:1
- Substance HNIDK
polysorbatum 80
- Substance HNIDK
natrii laurilsulfas
- Substance Hilfsstoff ohne Deklarationspflicht (Excipient sans obligation de déclaration)
natrium
0.09 MG Substance HBESI
cellulosum microcristallinum
- Substance HNIDK
dibutylis sebacas
- Substance HNIDK
silica colloidalis hydrica
- Substance HNIDK
calcii stearas
- Substance HNIDK
E 172 (nigrum)
- Substance FTODK
E 172 (rubrum)
- Substance FTODK
E 171
- Substance FNIDK
E 172 (flavum)
- Substance FTODK
gelatina
- Substance HNIDK
lacca
- Substance HNIDK
E 172 (nigrum)
- Substance FTODK
propylenglycolum
- Substance HNIDK
ammoniae solutio concentrata
- Substance HNIDK
kalii hydroxidum
- Substance HNIDK

Reimbursement information

Public price
CHF 27.45
Specialties list
Yes
Generic
Yes
SL addition date: 01/11/2021

Authorization holder

Exeltis Suisse SA

1228 Plan-Ies-Ouates

Authorization information

Swissmedic authorization number
68212
Drug name
Dutasterid-Tamsulosin Xiromed, Hartkapseln
Galenic form
KAHA
ATC Code
G04CA52
Authorization status
Z
Dispensing category
B
First authorization
03/09/2021
Authorization expiration date
31/12/9999
IT Number
05.99.0.
Domain
Human medicine
Field of application
Benigne Prostatahyperplasie

Package details

Description (FR)
DUTASTERIDE Tamsulosine Xiromed 0.5/0.4mg 30 pce
Description (DE)
DUTASTERID Tamsulosin Xiromed 0.5/0.4mg 30 Stk
Market launch
03/09/2021
Narcotic (BTM)
No

Original drug

Duodart, Hartkapseln
GTIN: 7680600950023
CHF 49.90
View original

Other package sizes (2)

DUTASTERIDE Tamsulosine Xiromed 0.5/0.4mg 7 pce
7 KAP
GTIN: 7680682120017
View
DUTASTERIDE Tamsulosine Xiromed 0.5/0.4mg 90 pce
90 KAP
GTIN: 7680682120031
View
Buy us a coffee Explore the data